Home
/
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
/
Financials
/
Quarterly
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 7, 2025
Q2
2025
Jun 30, 2025
$0
Aug 8, 2025
Q1
2025
Mar 31, 2025
$3.0K
May 9, 2025
Q3
2025
Sep 30, 2024
$0
Nov 7, 2025
Q2
2025
Jun 30, 2024
$8.0K
Aug 8, 2025
Q1
2025
Mar 31, 2024
$0
May 9, 2025
Q3
2024
Sep 30, 2023
$6.0K
Nov 8, 2024
Q2
2024
Jun 30, 2023
$0
Aug 9, 2024
Q1
2024
Mar 31, 2023
$0
May 10, 2024
Q3
2023
Sep 30, 2022
$55.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$0
Aug 11, 2023
Q1
2023
Mar 31, 2022
$15.0K
May 12, 2023
Q3
2022
Sep 30, 2021
$10.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$10.0K
Aug 12, 2022
Q1
2022
Mar 31, 2021
$0
May 13, 2022
Q3
2021
Sep 30, 2020
$77.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$27.9K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$42.1K
May 17, 2021
Q3
2020
Sep 30, 2019
$57.5K
Nov 13, 2020
Q2
2020
Jun 30, 2019
$61.6K
Aug 14, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.24M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.23M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($1.64M)
May 9, 2025
Q3
2025
Sep 30, 2024
($1.04M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($1.56M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($1.04M)
May 9, 2025
Q3
2024
Sep 30, 2023
($1.45M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($1.10M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($1.05M)
May 10, 2024
Q3
2023
Sep 30, 2022
($982.3K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.79M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($1.15M)
May 12, 2023
Q3
2022
Sep 30, 2021
($1.84M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($2.91M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
$27.84M
May 13, 2022
Q3
2021
Sep 30, 2020
$394.9K
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.84M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
$3.74M
May 17, 2021
Q3
2020
Sep 30, 2019
($2.41M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($88.2K)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.27M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.26M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($1.66M)
May 9, 2025
Q3
2025
Sep 30, 2024
($1.11M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($1.63M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($1.12M)
May 9, 2025
Q3
2024
Sep 30, 2023
($1.54M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($1.19M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($1.11M)
May 10, 2024
Q3
2023
Sep 30, 2022
($1.02M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.79M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($1.15M)
May 12, 2023
Q3
2022
Sep 30, 2021
($833.4K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($515.8K)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($303.9K)
May 13, 2022
Q3
2021
Sep 30, 2020
($242.5K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($214.3K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($335.0K)
May 17, 2021
Q3
2020
Sep 30, 2019
($273.4K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($275.5K)
Aug 14, 2020